Biography of Andrew Perry
Last update: March 21, 2024Career
Andrew was Vice President of US Marketing at ViiV Healthcare, and Field Vice President, National Accounts at GSK.
Andrew Perry is currently Chief Commercial Officer at G1 Therapeutics - View - G1 Therapeutics org chart
Create your alert
to follow the career of Andrew Perry.
Education
Andrew Perry has a Master of Arts in English Literature and Philosophy from University of Glasgow in 1993 and a Master of Science in Health Economics and Management from University of Sheffield in 1999.
They have also studied at University of Glasgow :
Find more alumni from University of Glasgow
They have also studied at University of Sheffield :
Find more alumni from University of Sheffield
More about Andrew Perry
Selected links
Do you need to know more about Andrew Perry? More results.
Participate
Social media
- Andrew Perry on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Andrew Perry
The colleagues of Andrew Perry
Company Colleagues
- At G1 Therapeutics, Andrew Perry has 16 colleagues including Jack Bailey (CEO), Garry Nicholson (Chairman of the Board)…
Homonyms
- Andrew Perry - Senior Legal Counsel - Cowi UK
- Andrew Perry - Marine Underwriting Manager, Western Region - HDI Global Australasia
- Andrew Perry - Chief Executive Officer, Latin America and Caribbean - Lockton International
- Andrew Perry - Chief Underwriting Officer, Political Risk, Credit, Property and Delegated Underwriting - Munich Re Syndicate
- View all the 4 org charts > Close
Industry Colleagues
- In the Biotechnology industry, Andrew Perry has 30,227 colleagues in 2,282 companies located in 40 countries. 14,408 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Andrew Perry.
Get in Touch
Sorry, but Andrew Perry cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of Andrew Perry listed below. Here are a few tips for establishing great contacts.
